1. Introduction {#sec1-molecules-14-01898}
===============

It is an established fact that oxadiazoles, imines and propanoates exhibits antimitotic \[[@B1-molecules-14-01898]\], antikinetoplastid \[[@B2-molecules-14-01898]\], antitussive \[[@B3-molecules-14-01898]\], hybrid COX-2 inhibitor/nitric oxide donor \[[@B4-molecules-14-01898]\], antimycotic \[[@B5-molecules-14-01898]\], anti-inflammatory \[[@B6-molecules-14-01898]\], analgesic \[[@B7-molecules-14-01898]\], antimicrobial and anticonvulsant \[[@B8-molecules-14-01898],[@B9-molecules-14-01898],[@B10-molecules-14-01898],[@B11-molecules-14-01898],[@B12-molecules-14-01898]\] activities. Moreover esters and hydrazides can be converted into imines, which are precursor for oxadiazoles \[[@B8-molecules-14-01898],[@B9-molecules-14-01898],[@B10-molecules-14-01898],[@B11-molecules-14-01898],[@B12-molecules-14-01898]\]. The literature has reported different biological activities and method of synthesis for oxadiazoles \[[@B1-molecules-14-01898],[@B2-molecules-14-01898],[@B3-molecules-14-01898],[@B4-molecules-14-01898],[@B5-molecules-14-01898],[@B6-molecules-14-01898],[@B7-molecules-14-01898],[@B8-molecules-14-01898],[@B9-molecules-14-01898],[@B10-molecules-14-01898],[@B11-molecules-14-01898],[@B12-molecules-14-01898]\]. Hence an attempt was made to convert some *N*-(substituted benzylidene)-3-phenylpropionohydrazides into novel 1-(2-aryl-5-phenethyl-1,3,4-oxadiazol-3(2H)-yl)ethanones. The novel compounds were characterized and further investigated for anti-bacterial and anti-fungal activities.

2. Results and Discussion {#sec2-molecules-14-01898}
=========================

2.1. Chemistry {#sec2dot1-molecules-14-01898}
--------------

The treatment of *N*-(substituted benzylidene)-3-phenylpropionohydrazides **1a-e**, with acetic anhydride yielded 1-(2-aryl-5-phenethyl-1,3,4-oxadiazol-3(2H)-yl)ethanones **2a-e** ([Scheme 1](#molecules-14-01898-sch001){ref-type="scheme"}).

The carbonylamino and imino groups in compounds **1a-e**, were found to cyclize to form oxadiazole rings when reacted with acetic anhydride. The assigned structures, molecular formulae and the anomeric configuration of the newly synthesized oxadiazoles **2a-e** were further confirmed and supported by mass, ^1^H-NMR and IR spectrometry. The fragmentation pattern of compound **2a** due to absence of C~8~H~9~, C~12~H~13~N~2~O~2~, C~16~H~19~N, C~12~H~14~N~3~O~2~, C~13~H~16~N~3~O~2~, C~15~H~18~N~3~O~2~ groups given in [Figure 1](#molecules-14-01898-f001){ref-type="fig"}, as an example further supported in identification of molecular structures of compounds **2a-e**.

The absence of specific group fragments in the mass spectra of compounds **2b-e** (C~8~H~9~, C~12~H~13~N~2~O~2~, C~14~H~13~Cl, C~10~H~8~ClN~2~O~2~, C~11~H~10~ClN~2~O~2~, C~13~H~12~ClN~2~O~2~ in the case of **2b;** C~8~H~9~, C~12~H~13~N~2~O~2~, -C~14~H~14~O~2~, C~10~H~9~N~2~O~4~, C~11~H~11~N~2~O~4~, C~13~H~13~N~2~O~4~ in **2c;** C~8~H~9~, C~12~H~13~N~2~O~2~, C~14~H~14~, C~10~H~9~N~2~O~2~, C~11~H~11~N~2~O~2~, C~13~H~13~N~2~O~2~ **2d**; and C~8~H~9~, C~12~H~13~N~2~O~2~, C~14~H~14~O, C~10~H~9~N~2~O~3~, C~11~H~11~N~2~O~3~, C~13~H~13~N~2~O~3~ in **2e**) was a key to establish their molecular structures. The purity of the compounds was checked by melting point, TLC and elemental analysis results, which were within ± 0.4% of the theoretical values.

2.2. Biological activity {#sec2dot2-molecules-14-01898}
------------------------

The newly synthesized compounds **2a-e** were screened for antibacterial activity against freshly cultured strains of *S. aureus* (SA) and *P. aeruginosa* (PA) using sterile nutrient agar media and for antifungal activity against freshly cultured strains of *C. albicans* (CA) and *A. flavus* (AF) using sterile sabouraud's agar medium by the disk diffusion method at a concentration of 2 mg per mL. using DMF as solvent. The results were recorded in duplicate using ampicillin and fluconazole at a concentration of 1 mg per mL as standards.

Among newly synthesized derivatives, compounds **2a** and **2b** were found to be equipotent to ampicillin when tested against the strains of *S. aureus*, and *P. aeruginosa*, whereas some of the newly synthesized compounds like **2a**, **2d** and **2e** were found to possess good antibacterial and antifungal activity when tested against *S. aureus*, *P. aeruginosa*, *C. albicans* and *A. flavus* ([Table 1](#molecules-14-01898-t001){ref-type="table"}).

3. Experimental Section {#sec3-molecules-14-01898}
=======================

3.1. General {#sec3dot1-molecules-14-01898}
------------

Melting points of newly synthesized compounds were determined using Thomas Hoover apparatus. IR spectra were recorded (in KBr) on a Bruker PCIR, ^1^H-NMR on Bruker, DPX 300 and mass spectra on MASPEC (MSW/9629). Purity of synthesized compounds was checked by TLC aluminium sheets -- silica gel 60 F254 (0.2 mm).

3.2. General procedure for the synthesis of 1-(2-aryl-5-phenethyl-1,3,4-oxadiazol-3(2H)-yl)ethanones *(**2a-e**)* {#sec3dot2-molecules-14-01898}
-----------------------------------------------------------------------------------------------------------------

A mixture of compound **1a-e** (0.01 mol) derived from 3-phenyl propane hydrazide was refluxed with acetic anhydride (0.01 mol) for 12 hours in the presence of zinc chloride. The product formed was isolated by filtration and recrystallized from methanol to yield compounds **2a-e.**

*1-(2-(4-(Dimethylamino)phenyl)-5-phenethyl-1,3,4-oxadiazol-3(2H)-yl)ethanone* (**2a**): Pale yellow crystals; Yield 65.8%; mp 225-226ºC; ^1^H-NMR δ (ppm): 2.04 (3H, s, -CO-CH~3~), 2.32 (2H, t, 6.9Hz, -CH~2~-C-O-), 2.65 (2H, t, 6.9Hz, Ar-CH~2~), 2.89 (6H, s, -N(CH~3~)~2~), 6.52 (2H, d, 8.1Hz, Ar-H3′ & 5′), 6.65 (1H, s, -N-CH-Ar′), 7.01 (2H, d, 8.2Hz, Ar′-H2′ & 6′), 7.18-7.31 (5H, m, Ar-H2, 3, 4, 5 & 6); FT-IR: 2924 (C-H of CH~2~), 1688 (C=O), 1611 (C=N), 1259 (C-O-C) cm^-1^; Anal. Calcd. for C~20~H~23~N~3~O~2~ (337.42): C: 71.19, H: 6.87, N: 12.45. found: C: 71.16, H: 6.85, N: 12.43; MS: m/z: 337 (M^+^), 232 (base peak), 120, 112, 105, 91, 65.

*1-(2-(4-Chlorophenyl)-5-phenethyl-1,3,4-oxadiazol-3(2H)-yl)ethanone* (**2b**): White crystals; Yield 64.9%; mp 212-213 °C; ^1^H-NMR δ (ppm): 2.11 (3H, s, -CO-CH~3~), 2.38 (2H, t, 6.5Hz, -CH~2~-C-O-), 2.72 (2H, t, 6.6Hz, Ar-CH~2~), 6.64 (1H, s, -N-CH-Ar′), 7.14 (2H, d, 8.3Hz, Ar′-H2′ & 6′), 7.20 (2H, d, 8.1Hz, Ar′-H3′ & 5′), 7.24-7.37 (5H, m, Ar-H2, 3, 4, 5 & 6); FT-IR: 1608 (C=N), 2928 (C-H of CH~2~), 1681 (C=O), 1256 (C-O-C) cm^-1^; Anal. Calcd. for C~18~H~17~N~2~O~2~Cl (328.79): C: 65.75, H: 5.21, N: 8.52. Found: C: 65.72, H: 5.20, N: 8.50; MS: m/z 328 (M^+^), 223 (base peak), 112, 111, 105, 91, 65.

*1-(2-(2,4-Dihydroxyphenyl)-5-phenethyl-1,3,4-oxadiazol-3(2H)-yl) ethanone* (**2c**): Yellow brown crystals; Yield 59.2%; mp 219-220 °C; ^1^H-NMR δ (ppm): 2.07 (3H, s, -CO-CH~3~), 2.32 (2H, t, 6.8Hz, -CH~2~-C-O-), 2.62 (2H, t, 6.8Hz, Ar-CH~2~), 5.22 (1H, s, 4-OH), 5.28 (1H, s, 2-OH), 6.14 (1H, d, 2.6 Hz, Ar′-H3′), 6.28 (1H, dd, 2.8, 7.6Hz, Ar′-H5′), 6.60 (1H, s, -N-CH-Ar′), 6.88 (1H, d, 7.9 Hz, Ar′-H6′), 7.19-7.32 (5H, m, Ar-H2, 3, 4, 5 & 6 ); FT-IR: 3516 (OH), 2926 (C-H of CH~2~), 1683 (C=O), 1617 (C=N), 1253 (C-O-C) cm^-1^; Anal. Calcd. for C~18~H~18~N~2~O~4~ (326.34): C: 66.25, H: 5.56, N: 8.58. Found: C : 66.22, H : 5.52, N : 5.54; MS: m/z 326 (M^+^), 221 (base peak), 112, 109, 105, 91, 65.

*1-(5-Phenethyl-2-phenyl-1,3,4-oxadiazol-3(2H)-yl)ethanone* (**2d**): White crystals; Yield 60.3%; mp 203-204 °C; ^1^H-NMR δ (ppm): 2.02 (3H, s, -CO-CH~3~), 2.30 (2H, t, 6.4Hz, -CH~2~-C-O-), 2.61 (2H, t, 6.5Hz, Ar-CH~2~), 6.61 (1H, s, -N-CH-Ar′), 7.15-7.29 (10H, m, Ar′ -H2′, 3′, 4′, 5′ & 6′ & Ar -H2, 3, 4, 5 & 6); FT-IR: 1610 (C=N), 2925 (C-H of CH~2~), 1686 (C=O), 1249 (C-O-C) cm^-1^; Anal. Calcd. for C~18~H~18~N~2~O~2~ (294.35): C: 73.45, H: 6.16, N: 9.52. Found: C: 73.42, H: 6.14, N: 9.50; MS: m/z 294 (M^+^), 189 (base peak), 105, 91, 77, 65.

*1-(2-(4-Hydroxyphenyl)-5-phenethyl-1,3,4-oxadiazol-3(2H)-yl)ethanone* (**2e**): Orange crystals; Yield 62.4%; mp 213-214 °C; ^1^H-NMR δ (ppm): 2.05 (3H, s, -CO-CH~3~), 2.35 (2H, t, 6.6Hz, -CH~2~-C-O-), 2.67 (2H, t, 6.5Hz, Ar-CH~2~), 5.26 (1H, s, 4-OH), 6.61 (1H, s, -N-CH-Ar′), 6.68 (2H, d, 7.8Hz, Ar′-H3′ & 5′), 7.03 (2H, d, 7.5Hz, Ar′-H2′ & 6′), 7.16-7.29 (5H, m, Ar-H2, 3, 4, 5 & 6); FT-IR: 3512 (OH), 2920 (C-H of CH~2~), 1680 (C=O), 1613 (C=N), 1249 (C-O-C) cm^-1^; Anal. Calcd. for C~18~H~18~N~2~O~3~ (310.34): C: 69.66, H: 5.85, N: 9.03. Found: C: 69.64, H: 5.82, N: 9.01; MS: m/z 310 (M^+^), 205 (base peak), 112, 105, 93, 91, 65.

4. Conclusions {#sec4-molecules-14-01898}
==============

Both analytical and spectral data (IR, ^1^H-NMR, MS) of all the synthesized compounds were in full agreement with the proposed structure. After comparing the antimicrobial results of compounds **2a-e**, it was concluded that the incorporation of an oxadiazole moiety in phenylpropionyl derivatives enhances their antimicrobial activity and also *para*-substitution in the Ar′ group of the oxadiazoles was found to enhance their potency, especially in compound **2a** and **2b**. Further studies to acquire more information about structure activity relationship are in progress in our laboratory.

The authors are thankful to CDRI, Lucknow, IIT Delhi and IIT Chennai for carrying out spectral studies. Thanks are also due to Rameesh Institute of Vocational and Technical Education, Greater Noida, for providing necessary facilities.

*Sample Availability:* Samples of the compounds **2a-e** are available from the authors.
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![Synthesis of Oxadiazoles **2a-e**.](molecules-14-01898-sch001){#molecules-14-01898-sch001}

![fragmentation pattern of oxadiazole **2a**.](molecules-14-01898-g001){#molecules-14-01898-f001}

molecules-14-01898-t001_Table 1

###### 

Antimicrobial activity-sensitivity testing of **2a-e**.

  -----------------------------------------------------------
  Compound\         Zone of inhibition in mm             
  No.                                                    
  ----------------- -------------------------- ---- ---- ----
  **2a**            24                         24   16   15

  **2b**            25                         24   15   13

  **2c**            23                         20   13   12

  **2d**            22                         23   16   13

  **2e**            19                         20   16   15

  **Ampicillin**    25                         24   \-   \-

  **Fluconazole**   \-                         \-   17   16
  -----------------------------------------------------------
